New drug combination increases overall survival in patients with PIK3CA-mutated advanced breast cancer - EurekAlert!
Overall survival and quality-of-life superiority in modern phase 3 oncology trials - EurekAlert!
First-line treatment with dual-targeted therapies and chemotherapy doubles overall survival in patients with BRAF-mutated metastatic colorectal cancer - EurekAlert!
Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer - EurekAlert
